The Promise and Potential of CAR T-Cell Therapy in Rheumatology: 
Emerging Evidence and Key Insights for Real-World Integration and Patient Care

Registration link: Click here 

Join our upcoming webinar to explore the transformative potential of CAR T-cell therapy in rheumatology!   

Originally developed for hematologic cancers, this cutting-edge treatment is now being investigated for autoimmune diseases like systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and idiopathic inflammatory myopathies (IIM) – showing promise in achieving durable, drug-free remission in patients with severe disease who have not responded to existing therapies. 

With new clinical trials and emerging data, this session will provide expert insights into the evolving evidence, practical considerations for patient selection, and interprofessional strategies to address the challenges of cost, complexity, and equitable access. 

Don’t miss this opportunity to hear directly from leading experts who have pioneered the study and application of CAR T-cell therapy in real-world settings so you can stay ahead of the curve in integrating this groundbreaking technology into rheumatology care. 

Plus, you can earn 1.5 CME/MOC! Register now for FREE.  

How To Participate 

This is a virtual event, so please register following these 3 easy steps:

1. Go to our registration page and register for the Summit.
2. Save your registration email with your link and login information.
3. Log in to the virtual meeting app during the Summit to participate!

The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!

Please note: you must register and complete the poll/survey questions in the virtual meeting app to claim your free CME credits.

Summit Details

Date: February 8th, 2025

Time: 12:00 PM – 15:20 EST

Location: Virtual with Community Locations

Chairs:

• Grace C. Wright, MD, PhD, FACR
  AWIR President and Founder
• Priya Reddy, MD, FACR
  AWIR Secretary and Treasurer

Speakers

• David L. Porter, MD
  Jodi Fisher Horowitz Professor of Leukemia Care Excellence
  Director, Center for Cell Therapy and Transplant
  University of Pennsylvania
• Peter A. Merkel, MD, MPH 
  Chief, Division of Rheumatology
  Professor of Medicine and Epidemiology
  University of Pennsylvania

Program

12:00-12:10 - Welcome Remarks

12:10-12:40  - Product Theater (Sponsored by UCB)

12:40-14:10 -  Accredited Session (1.5 CME/MOC) 

14:10-14:25 - Break

14:25-14:40 - Roundtable

14:40-15:10 - Product Theater (Sponsored by AbbVie)

15:10-15:20 - Closing Remarks

CME Session Information

Learning Objectives:

• Describe the principles, mechanisms, and administration of new and emerging CAR T-cell therapies.
• Evaluate the latest clinical safety and efficacy data on emerging CAR T-cell therapies for the treatment of rheumatic conditions. 
• Apply patient factors and disease characteristics to identify patients with rheumatic diseases who would benefit from CAR T-cell therapy.
  
• Incorporate interprofessional strategies for optimal access to, administration of, and monitoring of CAR T-cell therapies in patients with rheumatic diseases.  

Agenda: 

• Overview of CAR T-Cell Therapy: Principles, Mechanisms, and Administration
• Current Use of CAR T-Cell Therapy: Evidence and Experience in Hematology & Oncology
• Application of CAR T-Cell Therapy in Rheumatology: Clinical Trials and Early Data
  
• Integration of CAR T-Cell Therapy in Rheumatology: Patient Diversity and Eligibility, System and Team Resources, and Equitable Care

Registration link: Click here